POLYBODIES Trademark

Trademark Overview

On Wednesday, February 21, 2024, a trademark application was filed for POLYBODIES with the United States Patent and Trademark Office. The USPTO has given the POLYBODIES trademark a serial number of 79394107. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Thursday, June 5, 2025. This trademark is owned by National Institute Of Pharmaceutical Education And Research Niper. The POLYBODIES trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparation for use in the treatment of inflammation and inflammatory disorders
polybodies

General Information

Serial Number79394107
Word MarkPOLYBODIES
Filing DateWednesday, February 21, 2024
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateThursday, June 5, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, June 24, 2025

Trademark Statements

Goods and ServicesPharmaceutical preparation for use in the treatment of inflammation and inflammatory disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, April 25, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNational Institute Of Pharmaceutical Education And Research Niper
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressIN

Trademark Events

Event DateEvent Description
Thursday, April 25, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, May 6, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, September 11, 2024ASSIGNED TO EXAMINER
Friday, September 13, 2024NON-FINAL ACTION WRITTEN
Monday, September 16, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, May 6, 2024APPLICATION FILING RECEIPT MAILED
Saturday, September 14, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, September 16, 2024REFUSAL PROCESSED BY MPU
Monday, October 7, 2024REFUSAL PROCESSED BY IB
Tuesday, January 7, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, January 7, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, January 13, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 13, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, January 7, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, January 7, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, January 7, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, January 13, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Sunday, February 9, 2025FINAL REFUSAL E-MAILED
Sunday, February 9, 2025FINAL REFUSAL WRITTEN
Sunday, February 9, 2025NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, May 21, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 21, 2025TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, May 21, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, May 24, 2025EXAMINERS AMENDMENT E-MAILED
Saturday, May 24, 2025EXAMINERS AMENDMENT -WRITTEN
Saturday, May 24, 2025NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Saturday, May 24, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, May 24, 2025EXAMINER'S AMENDMENT ENTERED

Related Keywords

polybodies inflammatory disorders inflammation treatment preparation pharmaceutical